Literature DB >> 11055756

The impact of directly-observed treatment on the epidemiology of tuberculosis in Beijing.

L X Zhang1, D H Tu, D A Enarson.   

Abstract

SETTING: Fully supervised chemotherapy, or directly observed treatment (DOT), for newly detected smear-positive cases in Beijing, has been successfully implemented for two decades.
OBJECTIVE: To evaluate the progress made in tuberculosis control, and in particular to evaluate the impact of DOT on tuberculosis epidemiology in Beijing.
DESIGN: Epidemiological parameters on tuberculosis, consisting of mortality, prevalence, notification rate, tuberculous meningitis in children and initial drug resistance rate, were collected and analysed. Their trends were evaluated and compared with DOT implemented for new smear-positive cases in Beijing from 1978 to 1996.
RESULTS: The coverage of DOT for new smear-positive pulmonary tuberculosis cases has increased from 10% in 1978 to more than 90% since 1990. Since DOT was introduced in 1978, mortality from tuberculosis has declined by an average of more than 7% per year. The reduction rate of 17.2%, and the rates of chronic cases and tuberculous meningitis in children decreased dramatically. The rate of newly registered smear-positive cases decreased from 18.9/100000 in 1986 to 7.3/100000 in 1996, giving an average annual reduction rate of 9.1 during this period. Initial resistance to isoniazid and streptomycin decreased from respectively 13.9% and 12.3% in 1978-1979 to 4.2% and 5.8% by 1996. The level of multidrug resistance was low and stable, at 0.8% in 1996.
CONCLUSION: The experience of the Beijing tuberculosis control programme convincingly demonstrates that it is possible to improve the epidemiological situation rapidly in a low-income country, at very low cost and in a manner that is self-sufficient and sustainable.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11055756

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  11 in total

1.  Promoting adherence to treatment for tuberculosis: the importance of direct observation.

Authors:  Thomas R Frieden; John A Sbarbaro
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

2.  Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.

Authors:  R Sharma; D Saxena; A K Dwivedi; A Misra
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

3.  Drug-resistant tuberculosis in Shanghai, China, 2000-2006: prevalence, trends and risk factors.

Authors:  X Shen; K DeRiemer; Z-An Yuan; M Shen; Z Xia; X Gui; L Wang; Q Gao; J Mei
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

4.  Trends in tuberculosis incidence and their determinants in 134 countries.

Authors:  C Dye; K Lönnroth; E Jaramillo; B G Williams; M Raviglione
Journal:  Bull World Health Organ       Date:  2009-09       Impact factor: 9.408

5.  The experience of college students with pulmonary tuberculosis in Shaanxi, China: a qualitative study.

Authors:  Shao-Ru Zhang; Hong Yan; Jin-Jing Zhang; Tian-Hua Zhang; Xiao-Hong Li; Yin-Ping Zhang
Journal:  BMC Infect Dis       Date:  2010-06-16       Impact factor: 3.090

6.  From DOTS to the Stop TB Strategy: DOTS coverage and trend of tuberculosis notification in Ebonyi, southeastern Nigeria, 1998-2009.

Authors:  Kingsley Ukwaja; Isaac Alobu; Ngozi Ifebunandu; Chijioke Osakwe; Chika Igwenyi
Journal:  Pan Afr Med J       Date:  2011-05-31

7.  Tuberculosis trends in Saudis and non-Saudis in the Kingdom of Saudi Arabia--a 10 year retrospective study (2000-2009).

Authors:  Mohammad S Abouzeid; Alimuddin I Zumla; Shaza Felemban; Badriah Alotaibi; Justin O'Grady; Ziad A Memish
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

8.  Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia.

Authors:  Estifanos Biru Shargie; Bernt Lindtjørn
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

9.  Mycobacterium tuberculosis genotype and case notification rates, rural Vietnam, 2003-2006.

Authors:  Tran N Buu; Mai N T Huyen; Nguyen N T Lan; Hoang T Quy; Nguyen V Hen; Matteo Zignol; Martien W Borgdorff; Dick van Soolingen; Frank G J Cobelens
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

10.  The indirect cost due to pulmonary Tuberculosis in patients receiving treatment in Bauchi State-Nigeria.

Authors:  Nisser Ali Umar; Richard Fordham; Ibrahim Abubakar; Max Bachmann
Journal:  Cost Eff Resour Alloc       Date:  2012-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.